Vivesto AB (VIVE.ST)

SEK 0.24

(1.5%)

Inventory Summary of Vivesto AB

  • Vivesto AB's latest annual inventory in 2022 was - SEK , down -100.0% from previous year.
  • Vivesto AB's latest quarterly inventory in 2023 Q2 was - SEK , down 0.0% from previous quarter.
  • Vivesto AB reported annual inventory of 9.89 Million SEK in 2021, down -80.78% from previous year.
  • Vivesto AB reported annual inventory of 51.49 Million SEK in 2020, up 78.58% from previous year.
  • Vivesto AB reported quarterly inventory of - SEK for 2023 Q1, down 0.0% from previous quarter.
  • Vivesto AB reported quarterly inventory of 8.91 Million SEK for 2022 Q2, down -9.93% from previous quarter.

Annual Inventory Chart of Vivesto AB (2022 - 2004)

Historical Annual Inventory of Vivesto AB (2022 - 2004)

Year Inventory Inventory Growth
2022 - SEK -100.0%
2021 9.89 Million SEK -80.78%
2020 51.49 Million SEK 78.58%
2019 28.83 Million SEK 122.71%
2018 12.94 Million SEK 32.85%
2017 9.74 Million SEK -28.78%
2016 13.68 Million SEK -17.75%
2015 16.63 Million SEK 211.51%
2014 5.34 Million SEK 222.52%
2013 1.65 Million SEK 86.7%
2012 887 Thousand SEK 205.86%
2011 290 Thousand SEK 0.0%
2010 - SEK -100.0%
2009 94 Thousand SEK -96.61%
2008 2.77 Million SEK -85.48%
2007 19.12 Million SEK 4.38%
2006 18.31 Million SEK 585.14%
2005 2.67 Million SEK 0.0%
2004 - SEK 0.0%

Peer Inventory Comparison of Vivesto AB

Name Inventory Inventory Difference
AcuCort AB -1.09 Million SEK 100.0%
AlzeCure Pharma AB (publ) -2508.00 SEK 100.0%
BioGaia AB (publ) 181.2 Million SEK 100.0%
Enzymatica AB (publ) 11.49 Million SEK 100.0%
Enorama Pharma AB (publ) 4.29 Million SEK 100.0%
Gabather AB (publ) -1772.00 SEK 100.0%
Klaria Pharma Holding AB (publ.) - SEK NaN%
Moberg Pharma AB (publ) 7.11 Million SEK 100.0%
Nanexa AB (publ) 1.91 Million SEK 100.0%
Newbury Pharmaceuticals AB (publ) 4.99 Million SEK 100.0%
ODI Pharma AB - SEK NaN%
Orexo AB (publ) 42.4 Million SEK 100.0%
Probi AB (publ) 116.7 Million SEK 100.0%
Swedencare AB (publ) 398.1 Million SEK 100.0%
Swedish Orphan Biovitrum AB (publ) 3.87 Billion SEK 100.0%
Toleranzia AB -1.34 Million SEK 100.0%